... dialysis per population and a weak negative correlation with the prevalence of reduced kidney function in the population aged 40–74 years. Conclusion: We found a large regional variation in the frequency of inpatient percutaneous kidney biopsies. Kidney transplants and peritoneal dialysis might be offered...

... with iso-osmolar contrast media (CM). We report a case of contrast-induced encephalopathy (CIE) in a peritoneal dialysis (PD) patient, affected by diabetes, hypertension, and chronic heart failure. A 78-year-old PD patient (diuresis 1,000 mL) underwent a percutaneous angioplasty of the carotid. Immediately...

...: There are not enough data on the post-CO­VID-19 period for peritoneal dialysis (PD) patients affected from COVID-19. We aimed to compare the clinical and laboratory data of PD patients after COVID-19 with a control PD group. Methods: This study, supported by the Turkish Society of Nephrology, is a national...

.... 2022 Diabetes Continuous glucose monitoring Hemodialysis Peritoneal dialysis Time in range Hemoglobin A1c (HbA1c) was first identified more than 50 years ago and correlated to the mean plasma glucose of the previous 3–4 months [ 1, 2 ]. For both the dialysis and the general population...

... disease patients. However, the persistence of immune responses in the long term is not known yet. This study aimed to evaluate humoral immune responses in peritoneal dialysis (PD) patients over 6 months and to analyze the effects of the booster dose. Methods: Humoral immune responses of PD patients were...

... affect hemoglobin A 1c (HbA 1c ) levels in patients receiving peritoneal dialysis (PD). We compared HbA 1c with interstitial glucose measured by continuous glucose monitoring (CGM) in patients with type 2 diabetes receiving PD. Methods: Fourteen days of CGM (Ipro2, Medtronic) were performed in 23...

... as a consequence. Hydrostatic convection is a major drive for microvascular protein transport, but most studies in peritoneal dialysis (PD) patients overlooked this mechanism. An association between peritoneal protein clearance (PPCl) and venous congestion has been reported recently. The aim of this study...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Liraglutide Type 2 diabetes Chronic hemodialysis Diabetic nephropathy Peritoneal dialysis Diabetic kidney disease is the leading cause...

...Chih-Wei Chiu; Tsung-Hsun Tsai; Cheng-Li Lin; Tzung-Hai Yen; I-Kuan Wang; Chi-Yuan Li Background/Aims: This study investigated whether peritoneal dialysis (PD) patients using icodextrin were at a reduced risk of stroke. Methods: From Taiwan National Health Insurance data, it was found...

... to in the content or advertisements. End-stage renal disease Hemodialysis Peritoneal dialysis Morbid obesity Transplantation Dialysis dose Vascular access Obesity is an increasingly common health problem in most developed countries, particularly in the United States [ 1 ]. Obesity has grown...

... of this condition in patients undergoing peritoneal dialysis (PD) have been insufficiently investigated. Objectives and Method: Following a prospective, multicenter, observational design, we studied 237 patients who were treated with PD for ≥3 months, without any clinical background of cardiovascular (CV) disease...

... kidney disease; both are associated with all-cause and cardiovascular mortality. However, a link between them has not yet been established. The aim of this study was to analyze DD as a surrogate marker of fibrosis and its association with TH in incident patients on peritoneal dialysis (PD). Methods...

... in this population. The aim of this study was to assess nutrient intakes in hemodialysis (HD) and peritoneal dialysis (PD) patients. Methods: A clinical cross-sectional study was conducted over 7 days on 14 dialysis patients (98 days) who were trained to keep a weighed food record and a 7-day food diary. Nutrient...

...Ying Lu; Luyan Gao; Lingyun Li; Ye Zhu; Zhi Wang; Huaying Shen; Kai Song Background/Aims: Peritoneal fibrosis is one of the long-term complications in peritoneal dialysis (PD) patients. Recent evidences have suggested that hydrogen sulfide (H 2 S) is beneficial in treating various fibrotic diseases...

...Jialin Wang; Nan Zhu; Weijie Yuan Background: Glucose degradation products (GDPs) in peritoneal dialysis (PD) solution (PDS) have been shown to inflict damage to the kidney, which is the major organ for advanced glycosylation end product elimination. Hence, this study investigated whether new PDSs...

...Philip K.T. Li; Marc Dorval; David W. Johnson; Peter Rutherford; Evgeny Shutov; Ken Story; Joanne M. Bargman Background/Aims: Poor glycemic control can lead to increased morbidity and mortality in peritoneal dialysis (PD) patients. Serum fructosamine may be a more reliable marker of glycemic...

... as the social and emotional aspects, as these parameters may be associated with clinical outcomes in end-stage renal disease patients. Aim: To evaluate the impact of self-determined HRQOL at admission on survival of incident peritoneal dialysis (PD) patients. Patients and Methods: A total of 1,624 incident...

... undergoing continuous ambulatory peritoneal dialysis (CAPD). Nine clinically stable patients (1 male, 8 female; mean age 55.4 years; mean duration of CAPD 14.1 months) were studied. Twelve normal volunteers were studied as controls. GHRH and clonidine stimulation tests were performed prior to starting rhEPO...

...H.F.H. Brulez; H.A.T. Dekker; P.L. Oe; D. Verbeelen; P.M. ter Wee; H.A. Verbrugh The biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid (AA-PDF) was compared to that of a 2.27% glucose-based peritoneal dialysis fluid (G-PDF). Peritoneal macrophages (PMO), isolated from...

...Tor-Erik Widerøe; Ketil J. Dahl; Leif C. Smeby; Torveig Balstad; Sidsel Cruischank-Flakne; Ivar Følling; Ole Simondsen; Jarl Ahlmen; Størker Jørstad Seven type I insulin-dependent diabetic patients on continuous ambulatory peritoneal dialysis treatment were selected for this study. Each patient...